Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 3 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells.
Ann Hematol. 2024 Sep;103(9):3627-3637. doi: 10.1007/s00277-024-05762-4. Epub 2024 Apr 22.
Ann Hematol. 2024.
PMID: 38647678
Diallyl disulfide synergizes with melphalan to increase apoptosis and DNA damage through elevation of reactive oxygen species in multiple myeloma cells.
Hu W, Sun J, Zhang Y, Chen T, He F, Zhao H, Tan W, Wang Z, Ouyang J, Tang Z, He J, Wang J, Li J, Zeng X, Xia J.
Hu W, et al.
Ann Hematol. 2024 Apr;103(4):1293-1303. doi: 10.1007/s00277-023-05592-w. Epub 2023 Dec 27.
Ann Hematol. 2024.
PMID: 38148345
Item in Clipboard
Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1.
Sun W, Sun J, Hu W, Luo C, Lu Z, He F, Zhao H, Zeng X, Cao D, Li J, Zhang C, Xia J.
Sun W, et al.
Cancer Chemother Pharmacol. 2024 Dec 11;95(1):3. doi: 10.1007/s00280-024-04736-7.
Cancer Chemother Pharmacol. 2024.
PMID: 39661165
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.